RBC Capital Starts Endologix (ELGX) at Outperform
Tweet
Share
E-mailGet Alerts ELGX Hot Sheet
Price: $0.22 --0%
Rating Summary:
7 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
7 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
RBC Capital initiated coverage on Endologix (NASDAQ: ELGX) with an Outperform rating and a price target of $17.00.
For an analyst ratings summary and ratings history on Endologix click here. For more ratings news on Endologix click here.
Shares of Endologix closed at $13.90 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- Keefe, Bruyette & Woods Resumes Bank of Montreal (BMO:CN) (BMO) at Outperform
- BofA Securities Starts Mobility Global (MBGL) at Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
